Coronary thrombosis after Bentall’s procedure in a patient with Ehlers–Danlos syndrome: a case report Authors: Jixuan Zheng, Qin Yin, Yuqiang Wang, Xiaoting Li, Jun Shi Published: 2026 ABSTRACT BackgroundAcute coronary syndrome (ACS) following cardiac valve replacement is a rare but severe complication. Patients with vascular Ehlers-Danlos syndrome (vEDS) may exhibit an increased propensity for coronary thrombosis due to their genetic predisposition. After Bentall surgery, coronary manipulation and early postoperative anticoagulation instability may further contribute to thrombotic risk, particularly after mechanical valve implantation.Case presentationA 33-year-old male presenting with acute chest pain underwent a Bentall procedure for vEDS-complicated type A aortic dissection and received postoperative anticoagulation. Twenty days postoperatively, angiography and IVUS revealed a thrombus at the left anterior descending artery (LAD) ostium. Following a multidisciplinary discussion, percutaneous coronary intervention (PCI) was successfully performed to remove the thrombus and restore blood flow.ConclusionsWe discuss the risk of ACS following cardiac surgery, especially in vEDS patients, as well as strategies for early identification, timely intervention, and optimization of perioperative anticoagulation management.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13019-026-04343-y. Background ACS following cardiac valve replacement is a rare but severe complication which is significantly related with poor prognosis [1]. Besides, patients with vEDS may exhibit an increased propensity for coronary thrombosis due to their genetic predisposition [2]. Here, we present a case of an adult with Ehlers-Danlos syndrome complicated by coronary thrombosis after Bentall’s procedure. Case presentation A 33-year-old male was admitted to our hospital on January 28, 2024, due to chest tightness and chest pain (Fig. 1). He had been apparently healthy before this event, with no known history of mitral valve prolapse, aortic root dilation, prior arterial or venous thrombosis, chronic antithrombotic therapy, or a previously diagnosed heritable connective tissue disorder. The emergency physical examination did not document typical craniofacial, cutaneous, or joint findings suggestive of Ehlers-Danlos syndrome. Upon admission, the patient’s heart rate was 110 beats per minute, his blood pressure was 97/43 mmHg, and combined systolic and diastolic murmurs were heard at the left sternal border between the 3rd and 4th intercostal space. An electrocardiogram (ECG) indicated sinus tachycardia with widespread ST-segment depression and ST-segment elevation in leads aVR and V1(Supplementary Material 1). Laboratory tests revealed a BNP level of 178 ng/L (reference, < 100 ng/L) and a troponin T level of 190.1 ng/L (reference, < 14 ng/L). Arterial blood gas analysis revealed a pH of 7.288 (reference, 7.35–7.45), FiO2 of 100%, and PaO2 of 55 mmHg. Coronary angiography showed no significant stenosis. Computed tomography angiography suggested a suspicious circular tear at the root of the ascending aorta, which was consistent with Stanford type A aortic dissection (Supplementary Material 2). Echocardiography revealed an intimal flap in the ascending aorta, with an ejection fraction of 55%, and Doppler imaging revealed severe aortic valve regurgitation (Fig. 2). The clinical diagnosis was acute Stanford type A aortic dissection with severe aortic valve regurgitation. On January 29, a Bentall procedure was performed. The operation started at 11:03 and ended at 19:40, with a total surgical duration of 517 min. The perfusion record documented a total cardiopulmonary bypass time of 345 min (156 + 36 + 153 min) and an aortic cross-clamp time of 145 min (111 + 34 min). Intraoperative findings included a circular intimal tear at the sinotubular junction involving all three commissures and both coronary arteries, a trileaflet aortic valve with poor coaptation, and significant regurgitation at the valve orifice. The aortic wall was thin, fragile, and prone to bleeding, making hemostasis challenging. A 21-mm St. Jude Mechanical (SJM) valve combined with a MAQUET 26-mm synthetic vascular graft was implanted. No intracardiac thrombus or intraoperative coronary obstruction was reported, and temporary pacing wires were placed. Given the patient’s history of dissection and abnormal vascular manifestations during surgery, a connective tissue disorder was suspected. Molecular genetic testing revealed a missense mutation in the COL3A1 gene (c.2051G > A, heterozygous, p.Gly684Glu), confirming the diagnosis of vEDS [3]. Postoperatively, anticoagulation was started for the mechanical aortic valve with heparin-based bridging and warfarin 2.5 mg once nightly beginning on January 30. Notably, the patient developed overt bleeding manifestations, including subcutaneous ecchymosis, indicating an increased bleeding tendency. Anticoagulation intensity was adjusted repeatedly; warfarin was interrupted and subsequently restarted on February 13. INR was monitored continuously (Supplementary Material 3). Fig. 1Clinical timeline of events. The timeline summarizes admission on January 28, emergency Bentall surgery on January 29, the postoperative cTnT peak on January 31, clinical deterioration with dyspnea and hemoptysis on February 18, coronary angiography/IVUS-confirmed ostial LAD thrombosis and PCI, discharge on March 4, and 5-month follow-up. vEDS, vascular Ehlers-Danlos syndrome; cTnT, cardiac troponin T; IVUS, intravascular ultrasound; LAD, left anterior descending artery; PCI, percutaneous coronary intervention; EF, ejection fraction Clinical timeline of events. The timeline summarizes admission on January 28, emergency Bentall surgery on January 29, the postoperative cTnT peak on January 31, clinical deterioration with dyspnea and hemoptysis on February 18, coronary angiography/IVUS-confirmed ostial LAD thrombosis and PCI, discharge on March 4, and 5-month follow-up. vEDS, vascular Ehlers-Danlos syndrome; cTnT, cardiac troponin T; IVUS, intravascular ultrasound; LAD, left anterior descending artery; PCI, percutaneous coronary intervention; EF, ejection fraction Fig. 2Echocardiography indicated an intimal flap in the ascending aorta and severe aortic valve regurgitation. (A) Apical four-chamber view. (B) Parasternal long-axis color Doppler view showing severe aortic regurgitation; (C) diaphragmatic pericardial effusion. (D) Parasternal long-axis view showing the ascending aorta; the red circle indicates the intimal flap consistent with Stanford type A aortic dissection. LA, Left atrium; LV, Left ventricle; RA, Right atrium; RV, Right ventricle; AV, Aortic valve; Ao, Aorta Echocardiography indicated an intimal flap in the ascending aorta and severe aortic valve regurgitation. (A) Apical four-chamber view. (B) Parasternal long-axis color Doppler view showing severe aortic regurgitation; (C) diaphragmatic pericardial effusion. (D) Parasternal long-axis view showing the ascending aorta; the red circle indicates the intimal flap consistent with Stanford type A aortic dissection. LA, Left atrium; LV, Left ventricle; RA, Right atrium; RV, Right ventricle; AV, Aortic valve; Ao, Aorta The patient was transferred to the intensive care unit on January 29. From January 29, the BNP level fluctuated from 2,367 ng/L to 13,902 ng/L, whereas the troponin-T (cTnT) level initially rose from 1,242 ng/L to > 10,000 ng/L (on January 31) and subsequently decreased to 1,079 ng/L (Fig. 3). At the time of the cTnT peak, the elevation was initially interpreted as perioperative myocardial injury related to acute aortic dissection, prolonged cardiopulmonary bypass/cross-clamping, and myocardial protection during complex aortic root surgery. Because the biomarker level subsequently declined, no persistent ST-segment elevation myocardial infarction was documented, and immediate coronary angiography was considered high risk in the early postoperative period of vEDS and type A aortic dissection, diagnostic coronary angiography was deferred at that stage. The patient experienced persistent hemoptysis and reported dyspnea on February 18. An ECG was conducted (Supplementary Material 1). However, there were no typical findings indicative of LAD subocclusion. In terms of the patient’s symptoms, a echocardiography was conducted and revealed an ejection fraction (EF) of 39% and accelerated forward flow in the LAD artery, with a Vmax of 1.8 m/s. Segmental left ventricular wall motion abnormality was observed, with relatively preserved contractility in the inferior and inferolateral walls, while the remaining segments exhibited hypokinesia. In view of the new symptoms, reduced LVEF, and LAD flow acceleration, coronary angiography was considered clinically necessary despite the procedural risk. Coronary angiography demonstrated stenosis at the ostium of the LAD, whereas no significant stenosis was observed in other branches (Fig. 4). IVUS of the LAD indicated thrombus formation. Representative IVUS frames demonstrated intraluminal echogenic material compatible with thrombus formation (Supplementary Material 4). A minimally invasive 2.5 mm × 15 mm predilation balloon was used to expand the vessel, followed by thrombus aspiration in the LAD. Repeat coronary angiography confirmed restored blood flow in the LAD. Postoperatively, the patient returned to the ward in stable condition. The BNP level decreased from 13,902 ng/L to 7,074 ng/L (on February 19), and the cTnT level decreased from 1,079 ng/L to 398 ng/L (on February 19), with significant symptomatic improvement (Fig. 3). During the 5-month follow-up, echocardiography revealed an EF of 51%, a patent flow in the prosthetic ascending aorta, and no significant abnormalities in the prosthetic aortic valve. Fig. 3cTnT level during hospitalization. The line graph showed the postoperative trajectory of cTnT, with an early peak of > 10,000 ng/L on January 31 followed by gradual decline and a further decrease after coronary intervention. The x-axis showed calendar dates in 2024 (month/day), and the y-axis showed cTnT concentration in ng/L cTnT level during hospitalization. The line graph showed the postoperative trajectory of cTnT, with an early peak of > 10,000 ng/L on January 31 followed by gradual decline and a further decrease after coronary intervention. The x-axis showed calendar dates in 2024 (month/day), and the y-axis showed cTnT concentration in ng/L Fig. 4Coronary angiography indicated thrombosis formation in the left anterior descending branch. The red arrows indicated the ostial LAD thrombus/filling defect Coronary angiography indicated thrombosis formation in the left anterior descending branch. The red arrows indicated the ostial LAD thrombus/filling defect Discussion and conclusions This case describes a rare but clinically significant occurrence of coronary thrombosis 20 days after a Bentall procedure in a patient with vascular Ehlers–Danlos syndrome (vEDS). The pathogenesis is likely multifactorial, involving disease-specific vascular pathology, surgical factors, and postoperative antithrombotic management. Patients with vEDS may exhibit an increased propensity for thrombus formation due to their genetic predisposition. Mutations of the COL3A1 gene in vEDS patients disrupt the production of type III collagen, a critical structural component of vascular walls. This collagen deficiency renders blood vessels abnormally fragile, predisposing them to injury and tearing [2]. Vascular injury exposes subendothelial collagen, activating platelets and the coagulation cascade, thereby promoting localized thrombus formation [4]. Additionally, endothelial dysfunction in vEDS patients may disrupt the balance between anticoagulant and procoagulant factors. Dysfunctional endothelium can increase tissue factor expression, accelerate thrombin generation and subsequently exacerbate thrombogenesis [5, 6]. The inherent vascular fragility in vEDS may also lead to aneurysm or dissection formation, which alters local hemodynamics through turbulence or stasis, further elevating thrombotic risk [7]. In the present case, intrinsic vascular fragility combined with surgical manipulation likely amplified the local thrombogenic milieu. The Bentall procedure involves extensive vascular manipulation, including aortic root replacement and coronary artery reimplantation, which may predispose patients to postoperative complications such as coronary embolism [8]. Surgical manipulation of the coronary arteries during surgery can induce endothelial injury, triggering localized thrombus formation [9]. Inadequate postoperative anticoagulation therapy may further exacerbate blood hypercoagulability, contributing to thrombogenesis [10]. Additionally, the presence of a prosthetic aortic conduit may alter coronary hemodynamics, particularly if postoperative aortic stenosis or irregularity occurs, potentially increasing local flow turbulence and thrombotic risk [11, 12]. As a result, mitigating coronary thrombosis during perioperative management in cardiac surgery has become a challenge. The delayed onset of thrombosis in this case suggests a subacute process, likely involving progressive thrombus formation rather than an acute intraoperative complication. Postoperative antithrombotic management played a critical role in this case. The patient received perioperative anticoagulation with heparin or low-molecular-weight heparin. Postoperatively, anticoagulation was started for the mechanical aortic valve with heparin-based bridging and warfarin 2.5 mg once nightly beginning on January 30. Notably, the patient developed overt bleeding manifestations, including subcutaneous ecchymosis, indicating an increased bleeding tendency. Given the delayed onset and prolonged anticoagulant effect of warfarin, which may be difficult to reverse in the event of bleeding, warfarin was withheld and anticoagulation was maintained with heparin-based therapy to improve controllability. In addition, coagulation status in the early postoperative period is often unstable, making precise titration of warfarin challenging; thus, bridging anticoagulation with heparin represents a common and reasonable strategy. Despite these considerations, serial monitoring demonstrated that the international normalized ratio (INR) remained at a relatively low level. In the context of coronary reimplantation and altered hemodynamics following the Bentall procedure, this relatively low-intensity anticoagulation may have been insufficient to prevent thrombus formation. Particularly in the presence of endothelial injury, the balance between procoagulant and anticoagulant mechanisms may shift toward thrombogenesis. This case underscores the importance of individualized and dynamically adjusted antithrombotic strategies in patients with concurrent bleeding and thrombotic risks, with close monitoring of coagulation parameters such as prothrombin time and INR. From a clinical perspective, coronary thrombosis after cardiac surgery is uncommon but associated with poor outcomes if not promptly recognized [1, 13–15]. Postoperative presentations are often atypical, which may delay diagnosis. In this case, the patient presented with non-specific symptoms, including hemoptysis, dyspnea, respiratory distress, and elevated blood pressure. Although electrocardiography did not demonstrate typical features of acute coronary syndrome in this case, it remains an essential tool for the early identification of ACS in clinical practice. In postoperative and high-risk patients, ECG findings may be inconclusive or atypical. Therefore, a normal or non-diagnostic ECG should not exclude the possibility of coronary events. Given the persistent symptoms and high-risk background, further evaluation with coronary angiography and IVUS was performed, ultimately confirming thrombus formation at the ostium of the LAD. This diagnostic course emphasizes that, in high-risk patients, invasive imaging should be considered even in the absence of typical ECG changes. Percutaneous coronary intervention (PCI) remains the preferred reperfusion strategy in such cases, and early intervention is essential to restore coronary blood flow and improve clinical outcomes. Overall, this case highlights the complex interplay between bleeding and thrombosis in patients with vEDS undergoing major cardiovascular surgery. Coronary thrombosis in this context reflects not only surgical factors but also disease-specific vascular pathology and challenges in postoperative anticoagulation. Careful postoperative monitoring, early recognition of atypical symptoms, and individualized antithrombotic management are crucial to improving outcomes in this high-risk population. Supplementary Information Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3 Supplementary Material 4 Supplementary Material 4